The world’s leading vaccine producer, the Serum Institute of India is already able to produce 60 million doses of the formula developed by AstraZeneca and the University of Oxford each month. The selling price will be around 6 euros per unit.
It was during a socio-economic conference organized by theHindustan Times that Adar Poonawalla dropped a small bomb on Thursday, November 19. In a video intervention, the boss of the Serum Institute of India, the world’s largest vaccine manufacturer, claimed that a first vaccination campaign against Covid-19, “Could start next month” in the subcontinent, that is, in December.
The establishment, based in the city of Pune, near Bombay, declares itself ready to launch on the market Covishield, the vaccine developed by the Anglo-Swedish laboratory AstraZeneca and the University of Oxford. As soon as the British and European regulatory authorities have given the green light “In the context of an emergency procedure”, he will deposit “A marketing application from the Indian drug agency (Drug Controller in India)” and hope to get